<img height="1" width="1" src="https://www.facebook.com/tr?id=164483837374091&amp;ev=PageView&amp;noscript=1">
Blog menu
2019_EmbryoGlue webinar recording_1600x800

By Vitrolife, Mar 26, 2020

Current and Future Trends in PGT-A - Incorporating PGT-A into the IVF Journey [webinar recording]

Blog image_webinar recording

Chromosome aneuploidy (abnormal chromosome copy number) is a major cause of IVF failure, pregnancy loss and in rare cases, affected live births. Preimplantation genetic testing for aneuploidy (PGT-A), following culture to the blastocyst stage, trophectoderm biopsy, vitrification and testing by next generation sequencing (NGS) based methods for chromosome copy number analysis, is now widely used to identify embryos with normal chromosome copy number (euploid).

In this recorded webinar, Professor Alan Handyside reviews evidence for the effectiveness of PGT-A as an additional tool for embryo selection to improve clinical outcomes, particularly for single embryo transfers. Prof Handyside also considers how to implement PGT-A successfully and reviews prospects for non-invasive testing for aneuploidy (niPGT-A) using spent culture medium.

Watch webinar

 

Topics: genetic testing

Written by Vitrolife

Never miss a new blog post - Subscribe to Email Updates

Popular posts

Recent posts

Follow us